Junji Hanai

545 total citations
37 papers, 453 citations indexed

About

Junji Hanai is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Junji Hanai has authored 37 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Molecular Biology. Recurrent topics in Junji Hanai's work include Neuroblastoma Research and Treatments (28 papers), Neonatal Health and Biochemistry (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Junji Hanai is often cited by papers focused on Neuroblastoma Research and Treatments (28 papers), Neonatal Health and Biochemistry (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Junji Hanai collaborates with scholars based in Japan, China and United States. Junji Hanai's co-authors include Takeo Takeda, Nobuo Takasugi, Motoi Nishi, Hirotsugu Miyake, Yasumasa Sato, Masako Shimada, Yūko Kikuchi, Shinsuke Inagaki, Tatsuya Higashi and Toshimasa Toyo’oka and has published in prestigious journals such as Cancer, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Junji Hanai

37 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Hanai Japan 12 298 129 118 76 72 37 453
Michael Bennett United States 8 61 0.2× 253 2.0× 104 0.9× 137 1.8× 131 1.8× 11 524
Anna Synakiewicz Poland 10 73 0.2× 73 0.6× 23 0.2× 29 0.4× 30 0.4× 25 299
Wenhui Liao China 15 23 0.1× 215 1.7× 30 0.3× 53 0.7× 46 0.6× 32 523
Shigeru Hara Japan 6 34 0.1× 105 0.8× 45 0.4× 14 0.2× 47 0.7× 17 344
Ashwani Tandon India 8 25 0.1× 107 0.8× 18 0.2× 49 0.6× 33 0.5× 24 339
Rajesh Gupta United States 12 107 0.4× 61 0.5× 21 0.2× 6 0.1× 56 0.8× 58 510
Kazusaburo Kataoka Japan 12 29 0.1× 94 0.7× 43 0.4× 39 0.5× 197 2.7× 34 479
Kazutoshi Yokoyama Japan 11 48 0.2× 21 0.2× 32 0.3× 30 0.4× 104 1.4× 26 390
Alaa Sada United States 12 61 0.2× 87 0.7× 15 0.1× 40 0.5× 37 0.5× 40 469

Countries citing papers authored by Junji Hanai

Since Specialization
Citations

This map shows the geographic impact of Junji Hanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Hanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Hanai more than expected).

Fields of papers citing papers by Junji Hanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Hanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Hanai. The network helps show where Junji Hanai may publish in the future.

Co-authorship network of co-authors of Junji Hanai

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Hanai. A scholar is included among the top collaborators of Junji Hanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Hanai. Junji Hanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yan‐Hong, Yuanyuan Kong, Mei Diao, et al.. (2020). Repeatability and Reliability of Home-Based Stool Color Card Screening for Biliary Atresia Based on Results in China and Japan. The Tohoku Journal of Experimental Medicine. 252(4). 365–372. 8 indexed citations
2.
Yamagishi, Takuya, Junji Hanai, Toshihiro Tajima, et al.. (2013). Second-Tier testing of neonatal screening for congenital adrenal hyperplasia using Liquid Chromatography-tandem mass spectrometry. 23(1). 85–92. 3 indexed citations
3.
Higashi, Tatsuya, Masahiro Suzuki, Junji Hanai, et al.. (2011). A specific LC/ESI‐MS/MS method for determination of 25‐hydroxyvitamin D3 in neonatal dried blood spots containing a potential interfering metabolite, 3‐epi‐25‐hydroxyvitamin D3. Journal of Separation Science. 34(7). 725–732. 67 indexed citations
4.
Casella, Erasmo Barbante, María Aparecida Vieira, Débora Romeo Bertola, et al.. (2009). Spondylocostal Dysostosis Associated with Methylmalonic Aciduria. Genetic Testing and Molecular Biomarkers. 13(2). 181–183. 1 indexed citations
5.
Nishi, Motoi, Hirotsugu Miyake, Tomoki Takeda, et al.. (1998). The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.. Oncology Reports. 5(3). 631–3. 10 indexed citations
6.
Nishi, Motoi, et al.. (1998). Mass screening for neuroblastoma targeting children age 14 months in sapporo city. Cancer. 82(10). 1973–1977. 8 indexed citations
7.
Nishi, Motoi, et al.. (1998). Mass screening for neuroblastoma by HPLC and by non-HPLC: a review.. Oncology Reports. 5(6). 1399–402. 4 indexed citations
8.
Nishi, Motoi, Hirotsugu Miyake, Takeo Takeda, et al.. (1997). Mass screening for neuroblastoma and mortality in birth cohorts. International Journal of Cancer. 71(4). 552–555. 26 indexed citations
10.
Naito, Haruhiko, Takeo Takeda, & Junji Hanai. (1995). Failure to detect dopaminergic neuroblastoma in a mass-screening system. Journal of Pediatric Surgery. 30(9). 1317–1318. 2 indexed citations
11.
Nishi, Motoi, Hirotsugu Miyake, Takeo Takeda, et al.. (1993). Mass screening and occurrence of neuroblastoma in Sapporo City. 2(2-3). 99–104. 4 indexed citations
12.
Nishi, Motoi, et al.. (1991). Can a Patient with Neuroblastoma Be Diagnosed by a Single Urine Sample Collected Randomly?. Oncology. 48(1). 31–33. 2 indexed citations
13.
Nishi, Motoi, et al.. (1991). Mass Screening for Neuroblastoma and Estimation of Costs. Acta Paediatrica. 80(8-9). 812–817. 7 indexed citations
14.
Nishi, Motoi, Hirotsugu Miyake, Takeo Takeda, et al.. (1990). Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma. European Journal of Pediatrics. 149(12). 859–861. 3 indexed citations
15.
Nishi, Motoi, Hirotsugu Miyake, Takeo Takeda, et al.. (1990). Incidence of neuroblastoma in Sapporo City. Journal of Pediatric Surgery. 25(5). 545–546. 7 indexed citations
16.
Takeda, Takeo, et al.. (1989). Japanese experience of screening. Medical and Pediatric Oncology. 17(5-6). 368–372. 22 indexed citations
17.
Nishi, Motoi, et al.. (1989). Cases of Neuroblastoma Missed by the Mass Screening Programs. Pediatric Research. 26(6). 603–604. 20 indexed citations
18.
Nishi, Motoi, et al.. (1988). Effects of the mass screenings for neuroblastoma in Japan. European Journal of Pediatrics. 147(3). 308–311. 16 indexed citations
19.
Miyake, Hirotsugu, et al.. (1987). Establishment of Cut Off Values for Vanillylmandelic Acid an Homovanillic Acid in 24-Hr Urine Accumulation during Mass Screening for Neuroblastoma. Japanese Journal of Clinical Oncology. 17(3). 221–8. 2 indexed citations
20.
Sato, Yasumasa, Junji Hanai, Nobuo Takasugi, & Takeo Takeda. (1986). Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.. The Tohoku Journal of Experimental Medicine. 150(2). 169–174. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026